Catalyst Pharmaceuticals Inc
CPRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.85B
Close$
$16.80
46.7% downside
Current Fair Value
46.7% downsideOvervalued by 46.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.85 Billion |
|---|---|
| Enterprise Value | $3.10 Billion |
| Earnings per Share | $1.75 |
| Beta | 0.74 |
| Outstanding Shares | 122,254,171 |
Return
| Return on Equity | 21.85% |
|---|---|
| Return on Assets | 19.29% |
| Return on Invested Capital | 27.65% |
Valuation & Multiples
| P/E Ratio | 17.49 |
|---|---|
| PEG | 141.86 |
| Price to Sales | 7.87 |
| Price to Book Ratio | 3.94 |
| Enterprise Value to Revenue | 5.2 |
| Enterprise Value to EBIT | 11.05 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.48
Consensus analyst estimateRevenue Estimate
$155.79 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 1.82, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 1.8242▲ 51.01% |
|---|---|
| Total Calls | 45,500▼ 61.38% |
| Total Puts | 83,000▼ 46.38% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 89.17%▲ 3.58% |
|---|---|
| Total Invested | $3.42B▲ 32.14% |
| Investors Holding | 405▲ 13.00% |
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany
